MedPath

Cyclooxygenase inhibitor therapy in patients with oesophageal adenocarcinoma: A pilot study - CITA

Phase 1
Conditions
Oesophageal adenocarcinoma
Registration Number
EUCTR2005-000988-26-GB
Lead Sponsor
Portsmouth Hospitals NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
32
Inclusion Criteria

All patients with newly disgnosed, surgically resectable oesophageal adenocarcinoma.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Active peptic ulcer disease
History of asthma
Taking regular NSAIDs
Allergy to NSAIDs
History of significant cardiovascular disease
History of cerebrovascular disease
Hitory of moderate to severe renal failure

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath